Summary
71 / 100 · Bulios Score
What speaks for it
- Out of every 100 CLP of revenue, 25 CLP is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue growth is slowing: 1.7% a year over the last 3 years against 26% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.3 CLP for 1 CLP of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (CLP)
Diluted EPS (CLP)
- Analyst estimate
Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 1.7% a year. Earnings per share grew by 8.9% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 CLP of revenue goes
- Cost of sales 39 CLP
- Sales and administration 31 CLP
- Taxes and other 5.0 CLP
- Net profit 25 CLP
Net profit, industry median (Banks - Regional) 21 CLP
Out of every 100 CLP of revenue, 25 CLP is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 5
- Sell 1
No analyst has published a price target.
33% of the analysts recommend buying.
Analysts in detail